Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 59
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01923857 | Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function | ||
| NCT01067365 | Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism | ||
| NCT01800422 | Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer | ||
| NCT00882258 | Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | ||
| NCT01991327 | Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males | ||
| NCT01739582 | An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism | ||
| NCT01191320 | Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus | ||
| NCT02146391 | Study to Evaluate the Effect of Food Upon the Pharmacokinetics of Androxal | ||
| NCT00741273 | Evaluate the Safety and PK of Proellex® in Female Patients With Impaired Hepatic Function and Healthy Adults | ||
| NCT01069120 | Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids | ||
| NCT01069094 | A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata | ||
| NCT00881062 | Investigate Absorption, Metabolism and Excretion of [14C}-Proellex Following Single Oral Dose in Healthy Females | ||
| NCT02117830 | A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects | ||
| NCT01451424 | Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids | ||
| NCT00958334 | Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003 | ||
| NCT02169804 | An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal | ||
| NCT00741468 | Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects | ||
| NCT00853567 | Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids | ||
| NCT01386567 | A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203 | ||
| NCT01270841 | Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism | ||
| NCT00683917 | Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | ||
| NCT00787618 | Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females | ||
| NCT00706719 | To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone | ||
| NCT02811159 | An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids | ||
| NCT00881608 | Study to Evaluate Menses Induction in Women Administered Proellex | ||
| NCT02323646 | Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids | ||
| NCT01993212 | A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% | ||
| NCT01534208 | Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism | ||
| NCT00958412 | Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study | ||
| NCT01739595 | Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism | ||
| NCT01532414 | Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism | ||
| NCT02274181 | An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration | ||
| NCT01961908 | Open-Label Extension Study to ZPE-202 | ||
| NCT01187043 | Determination of the Lowest, Safe and Effective Dose of Proellex | ||
| NCT00749879 | Crossover Study of the Safety and PK Properties of Proellex® | ||
| NCT00785356 | Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids | ||
| NCT00962637 | Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism | ||
| NCT01959685 | A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal | ||
| NCT00619385 | A Safety and Pharmacokinetic Study of Proellex® | ||
| NCT01386606 | The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone) | ||
| NCT02651688 | A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene | ||
| NCT00702702 | Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids | ||
| NCT00874302 | Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms | ||
| NCT00620503 | Proellex® Pharmacokinetic Bridging Study II | ||
| NCT01631903 | Extension of Study ZPV-200 | ||
| NCT01739621 | Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200 | ||
| NCT01067807 | Proellex Pharmacokinetics Bridging Study | ||
| NCT01619683 | Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism | ||
| NCT02141061 | Comparison of Two Formulations of Proellex for Oral Administration | ||
| NCT00958893 | An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext |
